Literature DB >> 12894127

Quality of life issues in psoriasis.

Jane Choi1, John Y M Koo.   

Abstract

Psoriasis is associated with significant psychosocial morbidity and a decrease in health-related quality of life. It is important to view psoriasis as a serious disease and resist the tendency to underestimate its impact on overall patient well-being. The disability experienced by psoriasis sufferers is comparable to that of patients with other chronic illnesses such as heart disease, diabetes, cancer, and depression. Aggressive intervention is warranted in order to improve patient quality of life and decrease the potential for psychosocial sequelae. Health-related quality of life measures are becoming a necessary adjunct to traditional clinical assessments in the evaluation and treatment of psoriasis patients by the individual clinician. They also provide valuable information to government agencies and third party payers in the determination of resource allocation and reimbursement.

Entities:  

Mesh:

Year:  2003        PMID: 12894127     DOI: 10.1016/s0190-9622(03)01136-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  25 in total

1.  Evaluate the effect of cadmium on levels of zinc in scalp hair and blood samples of smoker and nonsmoker psoriatic patients at different stage.

Authors:  Suraya Samejo; Atif G Kazi; Hassan I Afridi; Tasneem G Kazi
Journal:  Environ Sci Pollut Res Int       Date:  2019-09-04       Impact factor: 4.223

2.  Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis.

Authors:  A Kavanaugh; C Antoni; G G Krueger; S Yan; M Bala; L T Dooley; A Beutler; C Guzzo; D Gladman
Journal:  Ann Rheum Dis       Date:  2005-08-11       Impact factor: 19.103

Review 3.  Fulfilling an unmet need in psoriasis : do biologicals hold the key to improved tolerability?

Authors:  Neil H Shear
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life: analysis of pooled data from two randomized, double-blind, placebo-controlled, multicentre clinical trials.

Authors:  Kim A Papp; James Signorovitch; Karthik Ramakrishnan; Andrew P Yu; Shiraz R Gupta; Yanjun Bao; Parvez M Mulani
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

5.  The Disruptiveness of Itchiness from Psoriasis: A Qualitative Study of the Impact of a Single Symptom on Quality of Life.

Authors:  Vanina L Taliercio; Ashley M Snyder; Lisa B Webber; Adelheid U Langner; Bianca E Rich; Abram P Beshay; Dominik Ose; Joshua E Biber; Rachel Hess; Jamie L W Rhoads; Aaron M Secrest
Journal:  J Clin Aesthet Dermatol       Date:  2021-06-01

Review 6.  Current and potential immune therapies and vaccines in the management of psoriasis.

Authors:  Benjamin H Kaffenberger; Grace L Lee; Kelly Tyler; Derek V Chan; Wael Jarjour; Maria E Ariza; Marshall V Williams; Henry K Wong
Journal:  Hum Vaccin Immunother       Date:  2014-02-03       Impact factor: 3.452

7.  Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.

Authors:  Abdul Rahman Khawaja; Syed Muhammad Azam Bokhari; Rasheed Tariq; Shahzad Atif; Hanif Muhammad; Qadeer Faisal; Mohammad Jafferany
Journal:  Prim Care Companion CNS Disord       Date:  2015-06-25

Review 8.  Evaluating Risk Tolerance from a Systematic Review of Preferences: The Case of Patients with Psoriasis.

Authors:  Juan Marcos Gonzalez
Journal:  Patient       Date:  2018-06       Impact factor: 3.883

Review 9.  Diet and psoriasis, part I: Impact of weight loss interventions.

Authors:  Maya Debbaneh; Jillian W Millsop; Bhavnit K Bhatia; John Koo; Wilson Liao
Journal:  J Am Acad Dermatol       Date:  2014-04-04       Impact factor: 11.527

10.  Topical and transdermal delivery with diseased human skin: passive and iontophoretic delivery of hydrocortisone into psoriatic and eczematous skin.

Authors:  Behnam Dasht Bozorg; Sonalika A Bhattaccharjee; Mahadevabharath R Somayaji; Ajay K Banga
Journal:  Drug Deliv Transl Res       Date:  2021-01-11       Impact factor: 5.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.